AI Summary
ABBV (ABBV) is currently trading at $223.71, up 2.27% in the last 24 hours. The P/E ratio of 166.3 suggests the market has high growth expectations. We maintain a HOLD rating pending clearer directional signals.
Price
Volume
P/E Ratio
Insider
Price Chart
Price Data
Fundamentals
Technical Analysis Summary
27 indicators analyzed
Technical signals are mixed with 9 bullish and 6 bearish indicators. Wait for clearer direction before taking new positions.
Technical Indicators
Momentum & trend signals
💡 Technical indicators are tools, not guarantees. Always combine with fundamental analysis.
MACD
(12, 26, 9)Bollinger Bands
Volatility & breakout detection
Stochastic Oscillator
Momentum indicator (14,3,3)
📊 Neutral: ABBV stochastic is in the middle range (77.2). Wait for %K to enter overbought (80+) or oversold (20-) zones for clearer signals.
Average True Range (ATR)
📊 Volatility increasing - consider wider stops to avoid getting stopped out.
On-Balance Volume (OBV)
Volume-based momentum indicator
📈 Volume confirms uptrend: OBV rising above its average suggests institutional accumulation. Bullish signal for trend continuation.
Pivot Points
Key Support & Resistance Levels
All Pivot Levels
Price is trading above the pivot point at $217.64, indicating bullish bias. Watch R1 ($221.25) as the next target.
Fibonacci Retracement
| Level | Price | Type | Distance |
|---|---|---|---|
| 0% | $244.81 | Resistance | -9.3% |
| 23.6% | $225.83 | Current | -0.8% |
| 38.2% | $214.09 | Support | +4.4% |
| 50%✦ | $204.60 | Support | +8.6% |
| 61.8%✦ | $195.11 | Support | +12.9% |
| 78.6% | $181.60 | Support | +18.9% |
| 100% | $164.39 | Support | +26.6% |
VWAP (Volume Weighted Avg Price)
Parabolic SAR
Stop and Reverse Indicator
🔄 TREND REVERSAL: SAR just flipped bearish! New downtrend starting. Consider short positions or exit longs.
Williams %R
⏸️ NEUTRAL: Williams %R at -22.8 - the stock is trading in the middle of its 14-day range. Momentum improving - watch for overbought zone above -20. Wait for extremes for clearer signals.
📊 CCI (Commodity Channel Index)
Momentum oscillator measuring price deviation
Strength: 60%
🔔 Crossover Alert: Zero Cross Up
Previous CCI
-47.9
Typical Price
$222.60
SMA (20)
$219.63
Mean Deviation
$2.86
⏸️ NEUTRAL: CCI at 69.1 - price trading within normal range. Momentum improving - watch for +100 breakout for buy signal. Wait for CCI to break ±100 levels for clearer trend signals.
20-Day CCI History
🎯Aroon Indicator(25-period)
📉 STRONG DOWNTREND: Aroon Down at 92 (above 70) with Aroon Up at 16 (below 30). Price made its 25-day low 2 day(s) ago. Trend is healthy - avoid buying or stay short. Oscillator at -76.0 shows bearish bias.
📊 Rate of Change (ROC)Buy
BullishUltimate Oscillator
Multi-timeframe momentum (7, 14, 28)
Keltner Channels
ATR-based volatility bands
⏸️ NEUTRAL: Price 223.96 is in the middle of the channel (EMA: 221.64). Channel width: 12.5%, ATR: 3.1% of price. No clear trend - wait for clearer signals.
TTM Squeeze
John Carter's Volatility Breakout
🔔 SQUEEZE ACTIVE (3 days)! Bollinger Bands are inside Keltner Channels - volatility is contracting. This builds energy for a big move. Momentum bias: Bullish (2.88). When squeeze fires, expect a move in the direction of momentum. Watch for the squeeze release!
Elder Ray (Bull/Bear Power)
Dr. Alexander Elder's Power Index
📈 Classic Elder Buy Signal: Uptrend with Bear Power negative but rising - bulls pulling price up from oversold.
Force Index
Dr. Alexander Elder's Volume-Price Momentum
⚠️ Mixed signals. Short-term force positive (10.32M) but medium-term still negative (-5.23M). Potential early reversal - wait for 13-EMA confirmation.
Williams Alligator
Trend Direction & Strength
😴 Alligator is SLEEPING - lines are tangled and intertwined. No clear trend exists. Price at $223.96 is above the lines. Avoid trading - wait for lines to separate and the Alligator to "wake up."
Donchian Channels
Richard Donchian's Breakout System (20-period)
Price at $223.96 is in the upper half of the 20-day Donchian Channel (204.27 - 229.79). Channel is stable with 11.8% width. Current trend: Downtrend.
Supertrend
ATR-Based Trend Following
📉 DOWNTREND active for 53 days. Price $223.96 is 2.0% below Supertrend $228.55. Moderate trend strength. The Supertrend line acts as resistance - avoid longs until bullish crossover.
Choppiness Index
Trend vs Range Detection (14-period)
⏳ TRANSITIONAL MARKET (CHOP: 48.6). The market is between trending and ranging. Choppiness is increasing (1.4 points). ⚠️ Choppiness increasing - trend may be ending. Be cautious with trend trades. Trading advice: WAIT for clearer signals or use smaller position sizes.
Valuation Metrics
Relative value indicators
💡 PEG < 1 suggests undervalued relative to growth • EV/EBITDA accounts for debt
Historical Returns
Price performance across timeframes
📈 Insight: Compare returns across timeframes to identify trends and momentum shifts.
Seasonality Analysis
Market Comparison
Performance vs S&P 500
Dividend History
Past payments & growth
| Ex-Date | Amount |
|---|---|
| Jan 16, 2026Latest | $1.7300 |
| Oct 15, 2025 | $1.6400 |
| Jul 15, 2025 | $1.6400 |
| Apr 15, 2025 | $1.6400 |
| Jan 15, 2025 | $1.6400 |
| Oct 15, 2024 | $1.5500 |
| Jul 15, 2024 | $1.5500 |
| Apr 12, 2024 | $1.5500 |
Growth Metrics
Year-over-year performance
Growth rates calculated from trailing twelve months vs prior period
Analyst EPS Estimates
Consensus earnings projections
| Fiscal Year | Est. EPS | YoY Growth |
|---|---|---|
| FY26 | $14.37 | +963.0% |
| FY27 | $16.24 | +13.0% |
| FY28 | $17.84 | +9.9% |
Based on analyst consensus estimates. Actual results may vary.
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
| Invalid Date | Unknown | SELL | 0 | $0K |
Recent News
CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder
AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth
Q4 Earnings Summary: Eli Lilly and AbbVie Beat, Uber Mixed
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
Better Long-Term Buy: This Emerging Player or the Industry Leader?
Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases
Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
Why Revolution Medicines Stock Plummeted by Almost 17% Today
Revolution Medicines Stock Sinks After Merck Deal Talks Collapse
Corticosteroids Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
💪 Strengths
- ✓Conservative debt levels provide stability
🚀 Opportunities
- →Market conditions could present buying opportunities
⚠️ Weaknesses
- !Thin profit margins limit flexibility
🛑 Threats
- ✕Broader market volatility remains a risk
⚡ Catalysts
- ★Earnings releases and guidance updates
⚠️ Key Risks
- !Standard market and sector risks apply
Are you an AI agent?
Help improve this research! Submit corrections, updates, or suggestions via Moltbook.
AI Agent Feedback
Are you an AI agent? Help improve this analysis!